Fortress Biotech (FBIO) Tax Provisions (2017 - 2026)
Fortress Biotech (FBIO) posted quarterly Tax Provisions of -$200000.0 for Q4 2025, down 159.52% year-over-year from $336000.0 in Q4 2024, and down 869.23% quarter-over-quarter from $26000.0 in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) Tax Provisions (2017 - 2026) Analysis & Trends
Fortress Biotech's Tax Provisions history runs 7 years deep, the most recent figure standing at -$200000.0 for Q4 2025.
- In Q4 2025, Tax Provisions fell 159.52% year-over-year to -$200000.0; the TTM figure through Dec 2025 stood at $262000.0 (down 39.91% YoY), while the FY2024 annual figure was $312000.0, down 37.6% from the prior year.
- Tax Provisions for Q4 2025 stood at -$200000.0, down from $26000.0 in the prior quarter.
- The five-year high for Tax Provisions was $473000.0 in Q4 2021, with the low at -$200000.0 in Q4 2025.
- The 5-year median for Tax Provisions is $218000.0 (2023), against an average of $205250.0.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions changed 0.0% in 2024, then slumped 159.52% in 2025.
- Fortress Biotech's Tax Provisions stood at $473000.0 in 2021, then dropped by 5.07% to $449000.0 in 2022, then dropped by 20.27% to $358000.0 in 2023, then declined by 6.15% to $336000.0 in 2024, then plunged by 159.52% to -$200000.0 in 2025.
- Business Quant data shows FBIO's Tax Provisions at -$200000.0 in Q4 2025, $26000.0 in Q3 2025, and $336000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 320,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 320,000.00 |
| Dec 31, 2025 | -7.22 Mn |
| Sep 30, 2025 | 26,000.00 |
| Dec 31, 2024 | 336,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Dec 31, 2023 | 379,000.00 |
| Sep 30, 2023 | 141,000.00 |
| Dec 31, 2022 | 449,000.00 |
| Dec 31, 2021 | 500,000.00 |
| Sep 30, 2018 | 944,000.00 |
| Jun 30, 2018 | 1.44 Mn |
| Dec 31, 2017 | 1.51 Mn |